Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Impact of Serum Albumin in the Prognosis of Myc-Positive Aggressive B-Cell Lymphomas: Potential for a Novel Prognostic Score

Chetasi Talati, MD, Andrew Kuykendall, MD, Jori Kaplan, MD, Jose D Sandoval-Sus, MD, Samir Dalia, MD, Bijal D. Shah, MD, Celeste M. Bello, MD, Farhad Khimani, MD, Paul A. Chervenick, MD, Ernesto Ayala, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Eduardo M. Sotomayor, MD, Lubomir Sokol, Julio C. Chavez, MD

Blood (2016) 128 (22): 1870.

https://doi.org/10.1182/blood.V128.22.1870.1870

Published: 2016

Journal Articles

Clinical Features and Outcomes of 24 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm-Single Institutional Experience

Afshan Idrees, MD, Xiaohui Zhang, MD PhD, Reza Setoodeh, MD, Samir Dalia, MD, Ling Zhang, MD, Lubomir Sokol, MD PhD

Blood (2015) 126 (23): 3755.

https://doi.org/10.1182/blood.V126.23.3755.3755

Published: 2015

Journal Articles

Sequential Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide Is a Safe and Effective Regimen for the Treatment of Previously Treated and Untreated CLL/SLL: The Hilo Trial

Javier Pinilla-Ibarz, Julio C Chavez, MD, Elyce Turba, RN, MSN, OCN, Lisa Nodzon, PhDANP, Jennifer rock-Klotz, BA, Samir Dalia, MD, Rami S. Komrokji, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Celeste M. Bello, MD

Blood (2015) 126 (23): 2941.

https://doi.org/10.1182/blood.V126.23.2941.2941

Published: 2015

Journal Articles

Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia after Ibrutinib Discontinuation Outside Clinical Trials: A Single Institution Experience

Jose D Sandoval-Sus, MD, Julio C Chavez, MD, Samir Dalia, MD, Celeste M. Bello, MD, Bijal D. Shah, MD, Viet Q. Ho, PharmD, RPh, BCOP, Lisa Nodzon, PhDANP, Mohamed A. Kharfan-Dabaja, MD, Eduardo M. Sotomayor, MD, Lubomir Sokol, MD PhD, Javier Pinilla-Ibarz

Blood (2015) 126 (23): 2945.

https://doi.org/10.1182/blood.V126.23.2945.2945

Published: 2015

Journal Articles

Multivariate Survival Analysis of Transformed Lymphoma in the Chemoimmunotherapy Era: Impact of the NCCN International Prognostic Index

Patrick T. Griffin, MD, Samir Dalia, MD, Bijal D. Shah, MD, Lubomir Sokol, MD PhD, Celeste M. Bello, MD, Paul A. Chervenick, MD, Eduardo M. Sotomayor, MD, Julio C Chavez, MD

Blood (2014) 124 (21): 2981.

https://doi.org/10.1182/blood.V124.21.2981.2981

Published: 2014

Journal Articles

Clinical Prognostic Factors and Outcomes of Essential Thrombocythemia When Transformed to Myelodysplastic Syndrome and Acute Myeloid Leukemia

Yaman Suleiman, MD, Samir Dalia, MD, Jijun Liu, MD, Jeremy W Bowers, MD, Eric Padron, MD, Jeffrey E Lancet, MD, Lynn C. Moscinski, MD, Rami S Komrokji, MD, Kenneth S. Zuckerman, MD, Ling Zhang, MD

Blood (2014) 124 (21): 1821.

https://doi.org/10.1182/blood.V124.21.1821.1821

Published: 2014

Journal Articles

Concurrent Epstein Barr Virus Viremia and Hodgkin Lymphoma In Two Patients With Chronic Lymphocytic Leukemia

Samir Dalia, MD, Jason B. Brayer, MD, PhD, Julio C Chavez, MD, Celeste M. Bello, MD, Bijal D. Shah, MD, Pedro Horna, M.D., Hailing Zhang, MD, Lubomir Sokol, MD, Ph.D, Eduardo M. Sotomayor, MD, Javier Pinilla-Ibarz, MD, PhD

Blood (2013) 122 (21): 5290.

https://doi.org/10.1182/blood.V122.21.5290.5290

Published: 2013

Journal Articles

A New Prognostic Index In Diffuse Large B-Cell Lymphoma Using Serum Albumin: A Pilot Study Evaluating The Albumin Adjusted-International Prognostic Index (A-IPI)

Samir Dalia, MD, Julio C Chavez, MD, Celeste M. Bello, MD, Paul A. Chervenick, MD, Bryan J Little, MPH, Najla H Al Ali, Lubomir Sokol, MD, Ph.D, Eduardo M. Sotomayor, MD, Ji-Hyun Lee, PhD, Kate Fisher, MA, Zachary Thompson, PhD, Bong-jin Choi, MA, Bijal D. Shah, MD

Blood (2013) 122 (21): 4267.

https://doi.org/10.1182/blood.V122.21.4267.4267

Published: 2013

Journal Articles

Locally Directed Therapy In Limited Stage Mantle Cell Lymphoma

Samir Dalia, MD, Julio C Chavez, MD, Celeste M. Bello, MD, Paul A. Chervenick, MD, Lubomir Sokol, MD, Ph.D, Jianguo Tao, MD, PhD, Eduardo M. Sotomayor, MD, Bijal D. Shah, MD

Blood (2013) 122 (21): 5057.

https://doi.org/10.1182/blood.V122.21.5057.5057

Published: 2013

Journal Articles

What Is The Optimal Dose Of Methotrexate In Primary Central Nervous System Lymphoma Treatment Regimens?

Samir Dalia, MD, Samantha L Price, PharmD, Peter Forsyth, MD, Celeste M. Bello, MD, Bijal D. Shah, MD, Lubomir Sokol, MD, Ph.D, Eduardo M. Sotomayor, MD, Michael V. Jaglal, MD

Blood (2013) 122 (21): 3040.

https://doi.org/10.1182/blood.V122.21.3040.3040

Published: 2013

Journal Articles

Extranodal Diffuse Large B Cell Lymphoma In The Rituximab Era and The Risk of Central Nervous System (CNS) Relapse. A Single Center Experience From 2008-2012

Christina Tsao, MD, Kate Fisher, MA, Ji-Hyun Lee, PhD, Julio C Chavez, MD, Samir Dalia, MD, Celeste M. Bello, MD

Blood (2013) 122 (21): 4330.

https://doi.org/10.1182/blood.V122.21.4330.4330

Published: 2013

Journal Articles

The Revised International Prognostic Index (R-IPI) Score Is Predictive Of Survival In Aggressive Transformed Lymphomas (TL) From Low Grade Non-Hodgkin Lymphomas In The Chemoimmunotherapy Era

Tsao Christina, MD, Samir Dalia, MD, Celeste M. Bello, MD, Lubomir Sokol, MD, Ph.D, Eduardo M. Sotomayor, MD, Bijal D. Shah, MD, Julio C Chavez, MD

Blood (2013) 122 (21): 4275.

https://doi.org/10.1182/blood.V122.21.4275.4275

Published: 2013

Journal Articles

Hepatitis B Infection Is Associated with an Increased Risk of Non-Hodgkin Lymphoma: A Meta-Analysis.

Samir Dalia, MD, Julio Chavez, MD, Jorge J Castillo, MD, Lubomir Sokol, MD, Ph.D

Blood (2012) 120 (21): 2658.

https://doi.org/10.1182/blood.V120.21.2658.2658

Published: 2012

Journal Articles

Higher Body Mass Index Is Associated with an Increased Risk of Diffuse Large B-Cell Lymphoma

Jorge J Castillo, MD, Randall R Ingham, II, MD, John L. Reagan, MD, Michael Furman, MD, Samir Dalia, MD, Saed Nemr, MD, Basma Merhi, MD, Joanna Mitri, MD

Blood (2012) 120 (21): 1605.

https://doi.org/10.1182/blood.V120.21.1605.1605

Published: 2012

Journal Articles

Incidence of Direct Thrombin Inhibitor Therapy for Presumed Heparin Induced Thrombocytopenia Before and After Implementation of Heparin Induced Thrombocytopenia IgG Subtype Antibody Test

Randall R Ingham, II, MD, John L. Reagan, MD, Samir Dalia, MD, Joseph D. Sweeney, MD, James N. Butera, MD

Blood (2012) 120 (21): 3336.

https://doi.org/10.1182/blood.V120.21.3336.3336

Published: 2012

Journal Articles

Gene Deletions of 17p or 11q Are Independent Predictors of Decreased Progression-Free Survival and Overall Survival Following Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia

Julio Chavez, MD, Jongphil Kim, PhD, Samir Dalia, MD, Mohamed A. Kharfan-Dabaja, MD, Javier Pinilla-Ibarz, MD, PhD, Claudio Anasetti, MD, Frederick L Locke, MD

Blood (2012) 120 (21): 2007.

https://doi.org/10.1182/blood.V120.21.2007.2007

Published: 2012

Journal Articles

Association Between Obesity/Overweight and Leukemia: A Meta-Analysis of Prospective Cohort Studies,

John L. Reagan, MD, Randall R Ingham, II, MD, Samir Dalia, MD, Michael Furman, MD, Basma Merhi, MD, Saed Nemr, MD, Ali Zarrabi, Joanna Mitri, MD, Jorge J Castillo, MD

Blood (2011) 118 (21): 3588.

https://doi.org/10.1182/blood.V118.21.3588.3588

Published: 2011

Journal Articles

The Relationship Between Obesity and Lymphoma: A Meta-Analysis of Prospective Cohort Studies

Randall R Ingham, II, MD, John L. Reagan, MD, Samir Dalia, MD, Michael Furman, MD, Basma Merhi, MD, Saed Nemr, MD, Ali Zarrabi, Joanna Mitri, MD, Jorge J Castillo, MD

Blood (2011) 118 (21): 5198.

https://doi.org/10.1182/blood.V118.21.5198.5198

Published: 2011

Journal Articles

Heparin Induced Thrombocytopenia; A Diagnostic Dilemma.

John L. Reagan, MD, Samir Dalia, MD, James N. Butera, MD

Blood (2009) 114 (22): 4468.

https://doi.org/10.1182/blood.V114.22.4468.4468

Published: 2009

NARROW

Impact of Serum Albumin in the Prognosis of Myc-Positive Aggressive B-Cell Lymphomas: Potential for a Novel Prognostic Score

Clinical Features and Outcomes of 24 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm-Single Institutional Experience

Sequential Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide Is a Safe and Effective Regimen for the Treatment of Previously Treated and Untreated CLL/SLL: The Hilo Trial

Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia after Ibrutinib Discontinuation Outside Clinical Trials: A Single Institution Experience

Multivariate Survival Analysis of Transformed Lymphoma in the Chemoimmunotherapy Era: Impact of the NCCN International Prognostic Index

Clinical Prognostic Factors and Outcomes of Essential Thrombocythemia When Transformed to Myelodysplastic Syndrome and Acute Myeloid Leukemia

Concurrent Epstein Barr Virus Viremia and Hodgkin Lymphoma In Two Patients With Chronic Lymphocytic Leukemia

A New Prognostic Index In Diffuse Large B-Cell Lymphoma Using Serum Albumin: A Pilot Study Evaluating The Albumin Adjusted-International Prognostic Index (A-IPI)

Locally Directed Therapy In Limited Stage Mantle Cell Lymphoma

What Is The Optimal Dose Of Methotrexate In Primary Central Nervous System Lymphoma Treatment Regimens?

Extranodal Diffuse Large B Cell Lymphoma In The Rituximab Era and The Risk of Central Nervous System (CNS) Relapse. A Single Center Experience From 2008-2012

The Revised International Prognostic Index (R-IPI) Score Is Predictive Of Survival In Aggressive Transformed Lymphomas (TL) From Low Grade Non-Hodgkin Lymphomas In The Chemoimmunotherapy Era

Hepatitis B Infection Is Associated with an Increased Risk of Non-Hodgkin Lymphoma: A Meta-Analysis.

Higher Body Mass Index Is Associated with an Increased Risk of Diffuse Large B-Cell Lymphoma

Incidence of Direct Thrombin Inhibitor Therapy for Presumed Heparin Induced Thrombocytopenia Before and After Implementation of Heparin Induced Thrombocytopenia IgG Subtype Antibody Test

Gene Deletions of 17p or 11q Are Independent Predictors of Decreased Progression-Free Survival and Overall Survival Following Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia

Association Between Obesity/Overweight and Leukemia: A Meta-Analysis of Prospective Cohort Studies,

The Relationship Between Obesity and Lymphoma: A Meta-Analysis of Prospective Cohort Studies

Heparin Induced Thrombocytopenia; A Diagnostic Dilemma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only